DUBLIN--(BUSINESS WIRE)--Jul 25, 2019--

Global Hematology Drugs Market Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global hematology drugs market.

Where is the largest and fastest growing market for the hematology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hematology Drugs market global report answers all these questions and many more.

The hematology drugs market consists of sales of hematology drugs and related services by entities (organizations, sole traders and partnerships) that produce hematology drugs to treat diseases such as genetic disorders, anemia, other related diseases. This industry includes establishments that produce blood products such as red blood cells, white blood cells, platelets, and fresh frozen plasma. It also consists of establishments which produce of anemia and other blood disorder drugs to treat anemia, hemophilia and blood clots.

Asia Pacific was the largest region in the global hematology drugs market, accounting for 35% of the market in 2018. North America was the second largest region accounting for 27% of the global hematology drugs market. Africa was the smallest region in the global hematology drugs market.

The increase in the number of drug approvals for hemophilia by the regulatory bodies such as FDA in the US is an emerging trend in the market. For instance, in June 2017, Novo Nordisk received FDA approval for its Rebinyn (Coagulation Factor IX (Recombinant), GlycoPEGylated) drug that is used in the treatment of hemophilia B. Over the last 17 years, there were no new drug approvals for the treatment of hemophilia.

However, there has been an uptake in the approval of new drugs for the treatment of hemophilia. From 2014 to 2017, seven new drugs have been approved by the FDA for treating hemophilia A and B. Increasing number of new FDA approved drugs aids in management of hemophilics and improves their Quality of Life (QoL).

Key Topics Covered:

1. Executive Summary

2. Report Structure

3. Hematology Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Hematology Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Hematology Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Hematology Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Hematology Drugs Market Trends And Strategies

8. Hematology Drugs Market Size And Growth

8.1. Market Size

8.2. Historic Market Growth, Value ($ Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value ($ Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Hematology Drugs Market Regional Analysis

9.1. Global Hematology Drugs Market, 2018, By Region, Value ($ Billion)

9.2. Global Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Region

9.3. Global Hematology Drugs Market, Growth And Market Share Comparison, By Region

10. Hematology Drugs Market Segmentation

10.1. Global Hematology Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)

10.1.1. Blood Products

10.1.2. Anemia And Other Blood Disorder Drugs

11. Hematology Drugs Market Metrics

11.1. Hematology Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global

11.2. Per Capita Average Hematology Drugs Market Expenditure, 2014 - 2022, Global

Companies Mentioned

  • Novo Nordisk A/S
  • Shire Plc
  • Bayer AG
  • Daiichi Sankyo Company
  • Biogen Inc

For more information about this report visit https://www.researchandmarkets.com/r/2p5888

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematological Drugs



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 07/25/2019 03:03 PM/DISC: 07/25/2019 03:03 PM

Copyright Business Wire 2019.